Showing results (411-420 of 580) with videos related to

Sort By:
Pageof 58
Neurochemical Research|July 1, 1987
Age-related alterations in the stimulated release in vitro of catecholamines and luteinizing hormone-releasing hormone from the male rat hypothalamusJ M Goldman, R L Cooper, G L Rehnberg, et al.
European Journal of Immunology|September 1, 1996
Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humansM A Naughton, M J Walport, R Würzner, et al.
Blood|December 1, 1975
Intensive leukapheresis as initial therapy for chronic granulocytic leukemiaR M Lowenthal, N A Buskard, J M Goldman, et al.
Bone Marrow Transplantation|March 7, 1998
Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantationJ O'Donnell, J M Goldman, K Wagner, et al.
Leukemia Research|January 1, 1983
1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cellsD M McCarthy, J F San Miguel, H C Freake, et al.
Bone Marrow Transplantation|March 7, 2003
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patientsE Terpos, J F Apperley, D Samson, et al.
British Journal of Haematology|May 31, 2001
Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: perpetuation by granulocyte colony-stimulating factorC F Pocock, G F Lucas, C Giles, et al.
Transplantation|October 1, 1989
Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantationE Kaminski, J Hows, S Man, et al.
British Journal of Cancer|February 1, 1986
Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year periodR E Marcus, D Catovsky, S A Johnson, et al.
Leukemia|August 1, 1993
Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: an updated meeting report and reviewM N Potter, N C Cross, J J van Dongen, et al.
Pageof 58